Hyunah Lee

Dr. Hyunah Lee

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
TBThomas Berger
Thomas Berger
HLHyunah Lee
Hyunah Lee
Allan YoungAllan Young
Allan Young
DADag Aarsland
Dag Aarsland
STSandrine Thuret
Sandrine Thuret

1 June 2018 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
HLHyunah Lee
Hyunah Lee
STSandrine Thuret
Sandrine Thuret

Verified
Journal Article
Open access
PDF file
RSRenato Santos
Renato Santos
HLHyunah Lee
Hyunah Lee
AWAlexander Williams
Alexander Williams
ABAnastasia Baffour-Kyei
Anastasia Baffour-Kyei
SLSang-Hyuck Lee
Sang-Hyuck Lee
AIAlfredo Iacoangeli
Alfredo Iacoangeli
Oxford Nanopore Technologies (ONT) long-read sequencing (LRS) has emerged as a promising genomic analysis tool, yet comprehensive benchmarks with established platforms across diverse datasets remain limited. This study aimed to benchmark LRS performance against Illumina short-read sequencing (SRS) and microarrays for variant detection across different genomic contexts and to evaluate the impact of experimental factors. We sequenced 14 human genomes using the three platforms and evaluated single nucleotide variants (SNVs), insertions/deletions (indels), and structural variants (SVs) detection, stratifying by high-complexity, low-complexity, and dark genome regions while assessing effects of multiplexing, depth, and read length. LRS SNV accuracy was slightly lower than that of SRS in high-complexity regions (F-measure: 0.954 vs. 0.967) but showed comparable sensitivity in low-complexity regions. LRS showed robust performance for small (1–5 bp) indels in high-complexity regions (F-measure: 0.869), but SRS agreement decreased significantly in low-complexity regions and for larger indel sizes. Within dark regions, LRS identified more indels than SRS, but showed lower base-level accuracy. LRS identified 2.86 times more SVs than SRS, excelling at detecting large variants (>6 kb), with SV detection improving with sequencing depth. Sequencing depth strongly influenced variant calling performance, whereas multiplexing effects were minimal. Our findings provide valuable insights for optimising LRS applications in genomic research and diagnostics.

1 April 2019 in Neurobiology of Aging
Verified
Journal Article
Open access
AGAriana Gatt
Ariana Gatt
HLHyunah Lee
Hyunah Lee
GWGareth Williams
Gareth Williams
STSandrine Thuret
Sandrine Thuret
CBClive Ballard
Clive Ballard
Alzheimer's disease (AD) is the most common form of dementia characterized by substantial neuronal loss and progressive brain atrophy. Animal studies have suggested that the process of adult neurogenesis might be altered at the earliest phases of disease onset. The relationship between AD progression and adult neurogenesis in the human brain is, however, not well understood. Here, we present a systematic review of the postmortem studies that investigated changes in human adult neurogenesis in the AD brain. We present findings from 11 postmortem studies that were identified by a systematic search within the literature, focusing on what markers of neurogenesis were used, which stages of AD were investigated, and whether the studies had any confounding information that could potentially hinder clear interpretation of the presented data. In addition, we also review studies that examined transcriptomic changes in human AD postmortem brains and reveal upregulated expression of neural progenitor and proliferation markers and downregulated expression of later neurogenic markers in AD. Taken together, the existing literature seems to suggest that the overall level of human adult neurogenesis is reduced during the later stages of AD, potentially due to failed maturation and integration of new-born neurons. Further investigations using complementary methods such as in vitro disease modeling will be helpful to understand the exact molecular mechanisms underlying such pattern of change and to determine whether neurogenesis can be an effective therapeutic target for early intervention.

27 August 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
CGCharlotte Greene
Charlotte Greene
HLHyunah Lee
Hyunah Lee
STSandrine Thuret
Sandrine Thuret
A certain degree of age-related cognitive decline is normal; however, some people retain more cognitive function than others. Cognitive impairment is associated with an increased risk of dementia. Thus, understanding the factors that contribute to cognitive reserve is crucial, so effective strategies for the prevention of dementia can be developed. Engaging in physical activity can delay cognitive decline and reduce the risk of dementia and a number of early life conditions have been shown to have long-lasting effects on cognition. This mini-review combines these two observations to evaluate the evidence from both animal models and epidemiological studies for physical activity in early life (≤ 30 years) delaying cognitive decline in later life (cognition tested ≥ 60 years). Three epidemiological studies were found; two showed a positive association and one found none. The latter was deemed to have an unreliable method. A review of animal studies found none that analysed the effect of physical activity in early life on cognition in later life. However, in rodent models that analysed mid-life cognition, runners showed improved cognition and enhanced adult hippocampal neurogenesis, changes which were preserved across the life span. Currently, there is insufficient evidence to conclude whether physical activity in early life may delay cognitive decline in later life, but these results indicate that further studies are warranted. Future human research should be in the form of longitudinal studies that begin below ≤ 15 years and assess sex differences. Crucially, the physical activity data must define type, quantity and intensity of exercise.

8 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TPTimothy R Powell
Timothy R Powell
TMTytus Murphy
Tytus Murphy
SLSang H. Lee
Sang H. Lee
RDRodrigo R. R. Duarte
Rodrigo R. R. Duarte
HLHyunah Lee
Hyunah Lee
STSandrine Thuret
Sandrine Thuret
Hippocampal volumes are smaller in psychiatric disorder patients and lower levels of hippocampal neurogenesis are the hypothesized cause. Understanding which molecular processes regulate hippocampal progenitor differentiation might aid in the identification of novel drug targets that can promote larger hippocampal volumes. Here we use a unique human cell line to assay genome-wide expression changes when hippocampal progenitor cells differentiate. RNA was extracted from proliferating cells versus differentiated neural cells and applied to Illumina Human HT-12 v4 Expression BeadChips. Linear regressions were used to determine the effect of differentiation on probe expression and we assessed enrichment for gene ontology (GO) terms. Genetic pathway analysis (MAGMA) was used to evaluate the relationship between hippocampal progenitor cell differentiation and adult hippocampal volume, using results from the imaging genomics consortium, ENIGMA. Downregulated transcripts were enriched for mitotic processes and upregulated transcripts were enriched for cell differentiation. Upregulated (differentiation) transcripts specifically, were also predictive of adult hippocampal volume; with Early growth response protein 2 identified as a hub transcription factor within the top GO term, and a potential drug target. Our results suggest that genes governing differentiation, rather than mitosis, have an impact on adult hippocampal volume and that these genes represent important drug targets.